Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion | RCV002283878 | SCV002573042 | pathogenic | Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome | 2022-09-01 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. Frameshift variant is predicted to result in a loss or disruption of normal protein function through protein truncation. Multiple pathogenic variants are reported in the predicted truncated region. The variant has been previously reported as de novo in a similarly affected individual (PMID: 31782611). The variant has been reported to be associated with POGZ -related disorder (PMID: 31782611). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. |